Standing Ovation raises $34.2 million to scale up its breakthrough technology for producing dairy proteins through precision fermentation, offering a sovereign and sustainable response to the surge in global demand for protein

Paris, March 31 (Bernama) -- Standing Ovation, a French precision fermentation pioneer producing next-generation proteins, has announced a $34.2 million (€30 million) Series B financing round, including $28.5 million in equity (€25 million), led jointly by the Ecotechnologies 2 fund—managed on behalf of the French government by Bpifrance as part of the France 2030 initiative— and Crédit Mutuel Innovation, alongside its existing investors—Astanor, Bel Group, Seventure Partners, GoodStartUp, and Big Idea Ventures—joined by Danone Ventures, Angelor, Newtree, and Noshaq. This investment is supplemented by $5.7 million (€5 million) in non-dilutive financing provided by Bpifrance and a leading banking syndicate.

This new funding round, which follows a €16 million Series A, will finance the commercial rollout of Standing Ovation’s proteins in the United States and, starting end of 2027, in Europe and Asia. The investment from French agri-food giants Groupe Bel and Danone serves as a powerful endorsement of Standing Ovation’s sustainable and sovereign model. Standing Ovation is redefining dairy protein production with a patented process that turns whey permeates into high-value caseins—a premium ingredient in critical demand across the global agrifood industry. The ability to repurpose dairy co-products, which are currently of little to no value, is a major milestone that reshapes the future of the ecosystem.